| Identification | Back Directory | [Name]
1H-[1,2,3]TRIAZOL-4-YLMETHYLAMINE HCL | [CAS]
118724-05-3 | [Synonyms]
1H-1,2,3-triazole-4-MethylaMine
1H-1,2,3-Triazole-5-MethanaMine
1H-1,2,3-Triazole-4-methanamine
1H-[1,2,3]Triazol-4-Ylmethylamine
(1H-1,2,3-Triazol-5-yl)methanamine
(1H-1,2,3-triazol-4-yl)MethanaMine
1-(2H-1,2,3-triazol-4-yl)methanamine
1H-[1,2,3]TRIAZOL-4-YLMETHYLAMINE HCL
C-(1H-[1,2,3]Triazol-4-yl)-MethylaMine
2H-triazol-4-ylmethanamine hydrochloride
1H-[1,2,3]triazol-4-ylmethylaminehydrochloride
(1H-1,2,3-Triazol-4-yl)MethanaMine hydrochloride
C-(1H-[1,2,3]TRIAZOL-4-YL)-METHYLAMINE HYDROCHLORIDE | [EINECS(EC#)]
808-365-5 | [Molecular Formula]
C3H6N4 | [MDL Number]
MFCD09701416 | [MOL File]
118724-05-3.mol | [Molecular Weight]
98.11 |
| Chemical Properties | Back Directory | [Melting point ]
140 °C (sublm)(Press: 0.01 Torr) | [Boiling point ]
298.0±15.0 °C(Predicted) | [density ]
1.322±0.06 g/cm3(Predicted) | [pka]
7.14±0.70(Predicted) |
| Hazard Information | Back Directory | [Uses]
1H-[1,2,3]Triazol-4-ylmethylamine HCl is used in the preparation of optimized 5-membered heterocycle-linked pterins for inhibition of ricin toxin A. Also used in the synthesis of orally bioavailiable human neurokinin-1 (hNK1) antagonists.
|
|
|